Great post by ozpolarbear - you are doing fantastic job, mate - love your work!
Based on PFS I am using simple and primitive logic to have an idea what to expect in SP when under production. Average EBITDA is expected to be circa US$250m so MC should be at least 8x this which equals US$2 bilion - in A$ roughly about 3 bilion. SP if not further diluted it would be about $13 but even with dilution 30% it would still be about $9. It's just for sake of simple exercise but pls DYO
- Forums
- ASX - By Stock
- Ann: Adriatic Metals Exceptional Pre Feasibility Study Vares
Great post by ozpolarbear - you are doing fantastic job, mate -...
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADT (ASX) to my watchlist
|
|||||
Last
$3.33 |
Change
-0.260(7.24%) |
Mkt cap ! $926.1M |
Open | High | Low | Value | Volume |
$3.50 | $3.52 | $3.25 | $2.993M | 888.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 2665 | $3.33 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.34 | 4854 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 6927 | 3.330 |
14 | 5891 | 3.320 |
11 | 14677 | 3.310 |
13 | 34659 | 3.300 |
9 | 5152 | 3.290 |
Price($) | Vol. | No. |
---|---|---|
3.340 | 19026 | 7 |
3.350 | 4714 | 11 |
3.360 | 31163 | 15 |
3.370 | 4628 | 9 |
3.380 | 4547 | 7 |
Last trade - 12.14pm 16/07/2024 (20 minute delay) ? |
Featured News
ADT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, CEO / Non-Exec Director
James Graham / Dr Alan Dunton
CEO / Non-Exec Director
SPONSORED BY The Market Online